ENSG

Business Context and Reporting Period

Company: The Ensign Group, Inc.
Filing Type: Form 10-Q (Unaudited)
Period Ended: June 30, 2009
Business Overview: Ensign operates 70 skilled nursing and assisted living facilities across seven states (California, Arizona, Texas, Washington, Utah, Colorado, and Idaho) with approximately 8,000 operational beds. The company is a holding company with no direct operating assets; all facilities are operated by separate, wholly-owned subsidiaries. As of June 30, 2009, the company owned 38 facilities and leased 32.

Key Financial Metrics

Note: EBITDA and EBITDAR are non-GAAP financial measures. EBITDAR excludes facility rent.

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 14.6% year-over-year for both the three and six-month periods, driven primarily by acquisitions (seven facilities acquired in the first half of 2009) and higher reimbursement rates for Medicare and Medicaid.
• Profitability: Net income increased 25.5% for the three months and 25.3% for the six months compared to the prior year periods. Operating margins improved slightly due to cost controls and higher skilled mix in same-facility operations.
• Occupancy: Overall occupancy decreased to 79.4% (Q3) and 79.6% (YTD) compared to 81.0% and 81.5% in the prior year, largely due to lower occupancy in recently acquired facilities.
• Acquisitions: The company spent approximately $22.1 million on business acquisitions in the first six months of 2009, adding 670 operational beds.
• Cost of Services: Increased 13.7% (Q3) and 13.8% (YTD), primarily due to higher salaries/benefits (replacing contract labor with full-time staff) and increased insurance costs.

Guidance, Outlook, Risks, and Contingencies

• Regulatory Investigation: The U.S. Department of Justice (DOJ) and U.S. Attorney's office are conducting an ongoing investigation into billing and reimbursement processes at certain facilities. Search warrants were served in December 2008, and subpoenas were issued in 2009. The company states it has not been formally charged but notes that the outcome could materially adversely affect financial condition.
• Reimbursement Risk: Approximately 75% of revenue is derived from Medicare and Medicaid. The company faces risks from potential rate reductions, cost-containment measures, and increased audit frequency (probe reviews).
• Liquidity: The company maintains a $50 million revolving credit facility with GE Capital. Borrowing capacity is restricted by a $6 million reserve related to the ongoing DOJ investigation. Management believes current cash and operating cash flow are sufficient for the next 12 months.
• Subsequent Event: Post-period, the company entered into an agreement to purchase additional real property and assets for approximately $17 million, though the transaction is not guaranteed.

Key Facts for Investor Verification

• Investigation Status: Verify the current status of the DOJ investigation and any potential financial accruals or penalties that may arise from billing irregularities.
• Acquisition Integration: Assess the performance and occupancy trends of the seven facilities acquired in the first half of 2009, which currently drag down overall occupancy metrics.
• Debt Covenants: Confirm continued compliance with debt covenants, particularly given the $6 million reserve restriction on the revolver and the cross-default provisions in master lease agreements.
• Payor Mix: Monitor the "Skilled Mix" and "Quality Mix" ratios, as a shift toward lower-reimbursing Medicaid patients could impact margins despite volume growth.
• Self-Insurance Reserves: Review the adequacy of self-insurance reserves for general liability and workers' compensation, as actuarial estimates can be volatile.